Skip to content
OpenCapital
Get started

Coya Therapeutics, Inc. COYA Q1 2026 earnings

Reported May 12, 2026 · Before market open

Revenue$300.0KBeat by $150.0K
EPS-$0.32Beat by $0.07
Revenue estimate$150.0K
EPS estimate-$0.39

Next report

Aug 11, 2026 (In 2 weeks)
Revenue estimate$130.0K
EPS estimate-$0.36

Versus estimates

Revenue

Q1 2026$300.0KBeat by $150.0K
Q4 2025$4.0MBeat by $1.8MQ3 2025$3.6MBeat by $1.6MQ2 2025$163.6KMiss by $619.7KQ1 2025$257.9KMiss by $2.4MQ4 2024$2.0KMiss by $98.0K

Diluted EPS

Q1 2026-$0.32Beat by $0.07
Q4 2025-$0.34Miss by $0.07Q3 2025-$0.10Miss by $0.12Q2 2025-$0.36Miss by $0.14Q1 2025-$0.44In lineQ4 2024-$0.18Beat by $0.08

Ask the moment Coya Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Coya Therapeutics, Inc. report Q1 2026 earnings?
Coya Therapeutics, Inc. (COYA) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Coya Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Coya Therapeutics, Inc. reported revenue of $300.0K and eps of $-0.32 for Q1 2026.
Did Coya Therapeutics, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $150.0K by $150.0K. EPS beat the consensus estimate of $-0.39 by $0.07.
How did Coya Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.3% from $257.9K a year earlier and eps grew 27.3% from $-0.44.
Where can I find Coya Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-218198) and the 10-Q periodic report (0001193125-26-218201) directly on SEC EDGAR. The filing index links above go to sec.gov.